Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Am Heart J. 2017 Jan 27;186:100–110. doi: 10.1016/j.ahj.2017.01.011

Table 1. Study Events Schedule.

Procedure Time point
Screening/enrollment Pre-drug During 24 Hours of drug Post Study Drug Completion (±3 h) Sooner of day 5 or Discharge 28-Day Phone Follow-up 3 Months
Informed Consent X
Inclusion/Exclusion Review X
Physical Exam Physician to complete after ICS is obtained (pre physical exam) AND within 12 hours after study dug is complete (post physical exam).
Doppler Echo X (optional) X
Blood draw X X
Blood Pressure X X
Borg Score X X X
SaO2% X Continuously
MtHb% X Continuously
Adverse Events Assessment X X X X
Outcome Assessment X
Dyspnea & Quality of Life Questionnaire X